Synjardy is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Empagliflozin; Metformin Hydrochloride.
| Product ID | 0597-0175_2f7eaca8-aa25-162f-af59-8682293e8590 | 
| NDC | 0597-0175 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Synjardy | 
| Generic Name | Empagliflozin And Metformin Hydrochloride | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2015-08-26 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA206111 | 
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. | 
| Substance Name | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 
| Active Ingredient Strength | 5 mg/1; mg/1 | 
| Pharm Classes | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],Biguanide [EPC],Biguanides [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2015-09-12 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA206111 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2015-09-12 | 
| Marketing Category | NDA | 
| Application Number | NDA206111 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2015-09-12 | 
| Marketing Category | NDA | 
| Application Number | NDA206111 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2015-09-12 | 
| Ingredient | Strength | 
|---|---|
| EMPAGLIFLOZIN | 5 mg/1 | 
| SPL SET ID: | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0597-0159 | Synjardy | empagliflozin and metformin hydrochloride | 
| 0597-0168 | Synjardy | empagliflozin and metformin hydrochloride | 
| 0597-0175 | Synjardy | empagliflozin and metformin hydrochloride | 
| 0597-0180 | Synjardy | empagliflozin and metformin hydrochloride | 
| 0597-0280 | Synjardy | empagliflozin, metformin hydrochloride | 
| 0597-0290 | Synjardy | empagliflozin, metformin hydrochloride | 
| 0597-0295 | Synjardy | empagliflozin, metformin hydrochloride | 
| 0597-0300 | Synjardy | empagliflozin, metformin hydrochloride | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() SYNJARDY  79145490  4590924 Live/Registered  | 
        Boehringer Ingelheim International GmbH  2014-02-17  |